Immunogen, Inc. (IMGN)

전일 마감가:

$31.23

열려 있는:

$0

하루 거래량:

0

시가총액:

$8.72B

수익:

$287.61M

순이익/손실:

$-73.52M

주가수익비율:

0.00

EPS:

-0.31

순현금흐름:

$-199.78M

1주 성능:

-100.00%

1개월 성능:

-100.00%

6개월 성능:

-100.00%

1년 성능:

-100.00%

1일 변동 폭

$0.00

$0.00

52주 변동 폭

$0.00

$31.25

Immunogen, Inc. Stock (IMGN) Company Profile

명칭

Immunogen, Inc.

부문

Healthcare (1191)

산업

Biotechnology (687)

전화

781-895-0600

주소

830 Winter Street, Waltham, MA

직원

293

트위터

@immunogeninc

다음 수익 날짜

2024-02-28

최신 SEC 제출 서류

IMGN's Discussions on Twitter

Immunogen, Inc. Stock (IMGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-01	다운그레이드	Guggenheim	Buy → Neutral
2023-11-20	개시	Goldman	Neutral
2023-11-09	개시	Deutsche Bank	Buy
2023-10-06	개시	Oppenheimer	Perform
2023-05-03	업그레이드	Piper Sandler	Neutral → Overweight
2022-11-21	개시	Truist	Buy
2022-09-09	개시	Barclays	Overweight
2022-03-21	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-02-11	개시	BMO Capital Markets	Outperform
2021-12-01	업그레이드	Jefferies	Hold → Buy
2020-10-26	재개	H.C. Wainwright	Buy
2020-10-02	업그레이드	Guggenheim	Neutral → Buy
2020-09-29	재개	JP Morgan	Neutral
2019-12-17	재확인	H.C. Wainwright	Buy
2019-08-13	재확인	H.C. Wainwright	Buy
2019-05-15	다운그레이드	Guggenheim	Buy → Neutral
2019-05-06	업그레이드	Cowen	Market Perform → Outperform
2019-05-06	업그레이드	H.C. Wainwright	Neutral → Buy
2019-03-19	다운그레이드	JP Morgan	Neutral → Underweight
2019-03-05	업그레이드	Morgan Stanley	Underweight → Equal-Weight
2019-03-04	다운그레이드	H.C. Wainwright	Buy → Neutral
2019-03-04	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-03-01	다운그레이드	Jefferies	Buy → Hold
2019-03-01	다운그레이드	Piper Jaffray	Overweight → Neutral
2018-09-07	개시	Piper Jaffray	Overweight
2018-02-08	재개	RBC Capital Mkts	Outperform
2018-01-31	개시	H.C. Wainwright	Buy
2017-07-06	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2017-04-19	업그레이드	Leerink Partners	Mkt Perform → Outperform
2016-04-29	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform

모두보기

Immunogen, Inc. 주식(IMGN)의 최신 뉴스

Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up

Zacks Investment Research

Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma

Zacks Investment Research

Ionis' (IONS) Eplontersen Gets Fast Track Tag for New Indication

Zacks Investment Research

Foghorn (FHTX) Jumps 55% as Lilly Takes Up FHD-909 Development

Zacks Investment Research

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?

Zacks Investment Research

Immunogen, Inc. (IMGN) 재무 분석

Immunogen, Inc. (IMGN) 매출 2024

Immunogen, Inc. (IMGN) 순이익 2024

Immunogen, Inc. (IMGN) 현금흐름 2024

Immunogen, Inc. (IMGN) 주당 순이익 2024